Consolidated Statement of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Dec. 25, 2021
Operating Activities
Net income	$ 9,155	$ 8,978	$ 7,679
Depreciation and amortization	2,948	2,763	2,710
Gain associated with the Juice Transaction	0	(3,321)	0
Impairment and other charges	1,230	3,618	0
Product recall-related impact	136	0	0
Operating lease right-of-use asset amortization	570	517	505
Share-based compensation expense	380	343	301
Restructuring and impairment charges	445	411	247
Cash payments for restructuring charges	(434)	(224)	(256)
Acquisition and divestiture-related charges	41	80	(4)
Cash payments for acquisition and divestiture-related charges	(41)	(46)	(176)
Pension and retiree medical plan expenses	150	419	123
Pension and retiree medical plan contributions	(410)	(384)	(785)
Deferred income taxes and other tax charges and credits	(271)	(873)	298
Tax expense related to the TCJ Act	0	86	190
Tax payments related to the TCJ Act	(309)	(309)	(309)
Change in assets and liabilities [Abstract]
Accounts and notes receivable	(793)	(1,763)	(651)
Inventories	(261)	(1,142)	(582)
Prepaid expenses and other current assets	(13)	118	159
Accounts payable and other current liabilities	420	1,842	1,762
Income taxes payable	310	57	30
Other, net	189	(359)	375
Net Cash Provided by Operating Activities	13,442	10,811	11,616
Investing Activities
Capital spending	(5,518)	(5,207)	(4,625)
Sales of property, plant and equipment	198	251	166
Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets	(314)	(873)	(61)
Proceeds associated with the Juice Transaction	0	3,456	0
Other divestitures, sales of investments in noncontrolled affiliates and other assets	75	49	169
Short-term investments, by original maturity:
More than three months - purchases	(555)	(291)	0
More than three months - maturities	556	150	1,135
More than three months - Sales	12	0	0
Three months or less, net	3	24	(58)
Other investing, net	48	11	5
Net Cash Used for Investing Activities	(5,495)	(2,430)	(3,269)
Financing Activities
Proceeds from issuances of long-term debt	5,482	3,377	4,122
Payments of long-term debt	(3,005)	(2,458)	(3,455)
Debt redemptions/cash tender offers	0	(1,716)	(4,844)
Short-term borrowings, by original maturity
More than three months - proceeds	5,428	1,969	8
More than three months - payments	(3,106)	(1,951)	(397)
Three months or less, net	(29)	(31)	434
Payments of acquisition-related contingent consideration	0	0	(773)
Cash dividends paid	(6,682)	(6,172)	(5,815)
Share repurchases - common	(1,000)	(1,500)	(106)
Proceeds from exercises of stock options	116	138	185
Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted	(140)	(107)	(92)
Other financing	(73)	(72)	(47)
Net Cash Used for Financing Activities	(3,009)	(8,523)	(10,780)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(277)	(465)	(114)
Net Increase/(Decrease) in Cash and Cash Equivalents and Restricted Cash	4,661	(607)	(2,547)
Cash and cash equivalents and restricted cash	$ 9,761	$ 5,100	$ 5,707